Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary Stent (Evolve)

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Boston Scientific Corporation

ClinicalTrials.gov Identifier:

NCT01135225

First received: May 31, 2010

Last updated: February 11, 2013

Last verified: February 2013

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	May 2016
Primary Completion Date:	August 2011 (Final data collection date for primary outcome measure)

No publications provided by Boston Scientific Corporation

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Meredith IT, Verheye S, Dubois CL, Dens J, Fajadet J, Carrié D, Walsh S, Oldroyd KG, Varenne O, El-Jack S, Moreno R, Joshi AA, Allocco DJ, Dawkins KD. Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. J Am Coll Cardiol. 2012 Apr 10;59(15):1362-70. Epub 2012 Feb 15.

To Top